Athenex Inc. acquires IP Group’s portfolio company Kuur Therapeutics for $185 million
LONDON: IP Group plc (LON: IPO) announced that its portfolio company Kuur Therapeutics Ltd has been acquired by Athenex Inc., a global biopharmaceutical company, for a total potential consideration of $185 million. Under the terms of the agreement, Athenex will…